DECREASED ACCESSORY CELL-FUNCTION OF MACROPHAGES AFTER INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVITRO

被引:42
作者
ENNEN, J
SEIPP, I
NORLEY, SG
KURTH, R
机构
[1] Paul-Ehrlich-Institute, Langen
关键词
D O I
10.1002/eji.1830201114
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peripheral blood monocytes from human immunodeficiency virus (HIV)‐infected individuals or AIDS‐related complex/AIDS patients ex vivo exhibit distinct alterations in some but not all immune functions. In studies presented here, monocytes from healthy donors were infected with HIV 1 in vitro and co‐cultures with autologous uninfected T lymphocytes were set up. The monocyte/macrophage (MΦ)‐dependent T cell function was determined by measurement of proliferative and secretory [interleukin (IL)2, interferon‐γ] responses to lectin (phytohemagglutinin), mitogen (anti‐CD3 monoclonal antibody), or recall antigen (tetanus toxoid, tuberculin). Accessory function of MΦ was normal after HIV infection when optimal amounts (10%–20%) were added to the T lymphocytes. However, HIV infection of MΦ significantly decreased T cell proliferative responses and secretion of IL 2 when supplemented at limited dilution (0.5%‐5%), although interferon‐γ production was not affected. Whereas the lipopolysaccharide‐triggered MΦ production of IL 1 was not impaired by HIV 1 infection, there was a significant decrease in this response when anti‐CD3 monoclonal antibody or tetanus toxoid were used to trigger the peripheral blood mononuclear cells. The impairment of proliferation of T lymphocytes in the presence of HIV 1‐infected MΦ could be overcome by addition of exogenous IL 1. Taken together, these data clearly show that the mononuclear phagocytedependent enhancement of stimulated T cell proliferation and lymphokine secretion is decreased when the restricted numbers of monocytes/MΦ are HIV 1 infected. There are, therefore, two possible roles of MΦ in HIV infection and progression to disease. First, as a reservoir and vehicle for dissemination of the virus, and second, as an immune cell whose essential functions are impaired by infection. Copyright © 1990 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
引用
收藏
页码:2451 / 2456
页数:6
相关论文
共 36 条
  • [1] MOLECULAR MECHANISMS IN TUMOR-CELL KILLING BY ACTIVATED MACROPHAGES
    ADAMS, DO
    NATHAN, CF
    [J]. IMMUNOLOGY TODAY, 1983, 4 (06): : 166 - 170
  • [2] BREEN EC, 1990, J IMMUNOL, V144, P480
  • [3] DOES OKT3 MONOCLONAL-ANTIBODY REACT WITH AN ANTIGEN-RECOGNITION STRUCTURE ON HUMAN T-CELLS
    CHANG, TW
    KUNG, PC
    GINGRAS, SP
    GOLDSTEIN, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03): : 1805 - 1808
  • [4] INTERACTION BETWEEN CD4 AND CLASS-II MHC MOLECULES MEDIATES CELL-ADHESION
    DOYLE, C
    STROMINGER, JL
    [J]. NATURE, 1987, 330 (6145) : 256 - 259
  • [5] THE EFFECT OF INTERLEUKIN-2 ON FC-GAMMA RECEPTOR FUNCTION OF HUMAN-MONOCYTES REQUIRES SPECIFIC INTERCELLULAR INTERACTION
    ENNEN, J
    ERNST, M
    FLAD, HD
    [J]. IMMUNOBIOLOGY, 1989, 179 (01) : 17 - 32
  • [6] THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS
    FAUCI, AS
    [J]. SCIENCE, 1988, 239 (4840) : 617 - 622
  • [7] THE ROLE OF MONONUCLEAR PHAGOCYTES IN HTLV-III LAV INFECTION
    GARTNER, S
    MARKOVITS, P
    MARKOVITZ, DM
    KAPLAN, MH
    GALLO, RC
    POPOVIC, M
    [J]. SCIENCE, 1986, 233 (4760) : 215 - 219
  • [8] THE MACROPHAGE IN THE PERSISTENCE AND PATHOGENESIS OF HIV INFECTION
    GENDELMAN, HE
    ORENSTEIN, JM
    BACA, LM
    WEISER, B
    BURGER, H
    KALTER, DC
    MELTZER, MS
    [J]. AIDS, 1989, 3 (08) : 475 - 495
  • [9] CD4+ LYMPHOCYTE FUNCTION WITH EARLY HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    GURLEY, RJ
    IKEUCHI, K
    BYRN, RA
    ANDERSON, K
    GROOPMAN, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) : 1993 - 1997
  • [10] INFECTION OF MONOCYTE MACROPHAGES BY HUMAN T-LYMPHOTROPIC VIRUS TYPE-III
    HO, DD
    ROTA, TR
    HIRSCH, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) : 1712 - 1715